Atlas FDA

TheraSphere

FDA premarket approval P200029/S009 · decided 2024-04-05

Approval details

PMA number
P200029
Supplement
S009
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TheraSphere
Generic name
Microspheres radionuclide
Applicant
Boston Scientific Corporation
Date received
2024-03-14
Decision date
2024-04-05
Days to decision
22 days
Decision code
OK30
Product code
NAW
Advisory committee
Radiology
Expedited review
No
Location
Marborough, MA
Statement
approval to enhance the criteria for visual sampling and inspection of the TheraSphere Administration Sets manufactured by B. Braun Medical Inc. during primary inspection at B. Braun and consequently reducing visual sampling and inspection during secondary inspection at BWXT Medical Ltd

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27